Enzalutamide can prolong survival in certain patients with prostate cancer, and delay occurrence of bone lesions. The new drug also offers advantages with regards to pain.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/7...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/7...